With over 20 years experience in senior HEOR & RWE leadership roles, Canter leads our group to provide clients with the path to access & improved patient outcomes through strategic planning, proven evidence generation methodologies, & effective value communications. His team is inspired to answer client’s most challenging clinical & commercial questions, as well as meet the highest standards of project delivery & compliance.
Canter also oversees HCG’s HEOR & RWE strategic partnerships with the industry’s leading health services & data providers to drive innovation & support our clients’ needs in a dynamic global market.

Kathy is a health services researcher with more than 20 years of experience managing real-world datasets and utilizing real-world data for clinical & economic research. She has extensive experience leading data-driven projects for pharmaceutical & medical device companies using many research designs across many therapeutic areas. Her research has been presented at national & international scientific conferences & published in peer-reviewed journals. Kathy also has experience with hospital quality initiatives, previously serving as analytics lead for a pay-for-performance demonstration pilot project with the Centers for Medicare & Medicaid Services.

Dr. Phillip Hivale has 10 + years in managed markets, value-based contracting, FDA/BLA policies, access and reimbursement, brand strategy, and health and economic outcomes. He has collaborated alongside numerous healthcare stakeholders and formulary decision-makers to gain consumer insights across payers, IDNs, and health systems. He has also worked directly with a number of pharmaceutical manufacturers to optimize their market access strategy and overall value messaging. Within a dynamically changing market, Phillip’s critical understanding of clinical and budget impact within the healthcare system has allowed him to provide an extremely unique expertise for each one of his clients.